As of 9:30 AM on the 3rd, Ilyang Pharmaceutical is trading at 49,150 KRW, the same price as the previous day. This represents a 54.32% increase compared to May 6. Ilyang Pharmaceutical is known as a pharmaceutical company specializing in drinks such as Wonbidi.
Over the past five days, individual investors have net purchased 172,173 shares, while foreigners and institutions have net sold 148,919 shares and 13,820 shares, respectively.
On May 29, Ilyang Pharmaceutical became a market issue with the news of 'COVID-19 treatment clinical trial approval causing consecutive surges.'
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
